Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0EQ1Z
|
||||
| Former ID |
DNC010108
|
||||
| Drug Name |
Isosorbide-2-benzylcarbamate-5-(o-toluate)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H23NO6
|
||||
| Canonical SMILES |
CC1=CC=CC=C1C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4
|
||||
| InChI |
1S/C22H23NO6/c1-14-7-5-6-10-16(14)21(24)28-17-12-26-20-18(13-27-19(17)20)29-22(25)23-11-15-8-3-2-4-9-15/h2-10,17-20H,11-13H2,1H3,(H,23,25)/t17-,18+,19-,20-/m1/s1
|
||||
| InChIKey |
XMIPVPSZMVVUST-IYWMVGAKSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | J Med Chem. 2010 Feb 11;53(3):1190-9.Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.